Prevalence of Non-Alcoholic Fatty Liver Disease and Risk Factors for Advanced Fibrosis and Mortality in the United States

PLoS ONE - United States
doi 10.1371/journal.pone.0173499
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Re-Discussion on Linearity Between Fibrosis Stages and Mortality Risk in Non-Alcoholic Fatty Liver Disease Patients

Hepatology
MedicineHepatology
2017English

Prevalence of and Risk Factors for Non-Alcoholic Fatty Liver Disease (NAFLD) in Community-Dwellers of Beijing, China

OA Evidence-Based Medicine
2013English

Cardiovascular Risk Factors in Patients With Non Alcoholic Fatty Liver Disease

Journal of Evolution of Medical and Dental sciences
2013English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Prevalence of Non-Alcoholic Fatty Liver Disease and Associated Risk Factors Among Managers From the Community of Madrid

Archivos de Prevención de Riesgos Laborales
2014English

Liver Fibrosis Scores Predict Liver Disease Mortality in the United States Population

Hepatology
MedicineHepatology
2017English

Current Modalities of Fibrosis Assessment in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Translational Hepatology
2017English

Emerging New Standard for Non-Invasive Assessment of Liver Disease Mortality in Non-Alcoholic Fatty Liver Disease

HepatoBiliary Surgery and Nutrition
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy